Zobrazeno 1 - 10
of 75
pro vyhledávání: '"R. P. Myasnikov"'
Autor:
I. A. Skripnikova, E. K. Yaralieva, R. P. Myasnikov, O. V. Kulikova, V. E. Novikov, O. V. Kosmatova, V. A. Vygodin, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 6, Pp 557-564 (2023)
Aim. To assess the body composition and functional activity (FA) parameters in men with heart failure (HF) of various nature depending on the stage, class and echocardiographic characteristics of the disease.Material and methods. The study included 1
Externí odkaz:
https://doaj.org/article/547ad3c1b15648b99d8afe6557b9c765
Autor:
E. A. Mershina, D. A. Filatova, M. V. Lisitskaya, E. V. Ryzhkova, R. P. Myasnikov, V. E. Sinitsyn
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 6, Pp 565-571 (2023)
An increase in left ventricular (LV) extracellular volume (ECV) is an important parameter of LV morphology and is considered synonymous with myocardial fibrosis, as well as a reliable marker of myocardial injury and impaired cardiac function. Accurat
Externí odkaz:
https://doaj.org/article/8174408090484e24aeb0fc5ee4317c7d
Autor:
O. M. Drapkina, A. V. Kontsevaya, A. M. Kalinina, S. N. Avdeev, M. V. Agaltsov, L. I. Alekseeva, I. I. Almazova, E. Yu. Andreenko, D. N. Antipushina, Yu. A. Balanova, S. A. Berns, A. V. Budnevsky, V. V. Gainitdinova, A. A. Garanin, V. M. Gorbunov, A. Yu. Gorshkov, E. A. Grigorenko, B. Yu. Jonova, L. Yu. Drozdova, I. V. Druk, S. O. Eliashevich, M. S. Eliseev, G. Zh. Zharylkasynova, S. A. Zabrovskaya, A. E. Imaeva, U. K. Kamilova, A. D. Kaprin, Zh. D. Kobalava, D. V. Korsunsky, O. V. Kulikova, A. S. Kurekhyan, N. P. Kutishenko, E. A. Lavrenova, M. V. Lopatina, Yu. V. Lukina, M. M. Lukyanov, E. O. Lyusina, M. N. Mamedov, B. U. Mardanov, Yu. V. Mareev, S. Yu. Martsevich, N. P. Mitkovskaya, R. P. Myasnikov, D. V. Nebieridze, S. A. Orlov, K. G. Pereverzeva, O. E. Popovkina, V. I. Potievskaya, I. A. Skripnikova, M. I. Smirnova, T. M. Sooronbaev, N. V. Toroptsova, Zh. V. Khailova, V. E. Khoronenko, M. G. Chashchin, T. A. Chernik, S. A. Shalnova, M. M. Shapovalova, R. N. Shepel, A. F. Sheptulina, V. N. Shishkova, R. U. Yuldashova, I. S. Yavelov, S. S. Yakushin
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 3 (2024)
Создание руководства поддержано Советом по терапевтическим наукам отделения клинической медицины Российской академии наук.
Externí odkaz:
https://doaj.org/article/be1bf718a83641c9bbdec3186ac2921b
Autor:
E. A. Mershina, D. A. Filatova, R. P. Myasnikov, O. V. Kulikova, A. N. Meshkov, A. V. Kiseleva, V. E. Sinitsyn, M. S. Kharlap
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 3 (2024)
Aim. To analyze contrast-enhanced cardiac magnetic resonance imaging (MRI) in patients with phenotypic manifestations of left ventricular non-compaction (LVNC) and related genetic mutations, as well as to determine the relationship between mutations
Externí odkaz:
https://doaj.org/article/bb7484119c08431da236aa0f35cfd4d8
Autor:
F. B. Shukurov, R. P. Myasnikov, O. V. Kulikova, D. A. Nefedova, D. A. Feshchenko, D. K. Vasiliev
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 2 (2024)
The revascularization strategy for severe calcification is one of the most pressing problems of modern percutaneous coronary interventions, since it is observed more and more often and significantly complicates traditional endovascular treatment. Cur
Externí odkaz:
https://doaj.org/article/5a8d32e3314e4721a5a1ae1ec9de2790
Autor:
M. M. Kudryavtseva, E. V. Ryzhkova, O. V. Kulikova, E. A. Mershina, V. E. Sinitsyn, O. M. Drapkina, R. P. Myasnikov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 2 (2024)
Left ventricular (LV) hypertrophy implies structural cardiac changes and, as a consequence, an increase in myocardial mass. Currently, there are many causes of this condition as follows: hypertension, aortic stenosis, hypertrophic cardiomyopathy, exe
Externí odkaz:
https://doaj.org/article/8ca17cb5493a455c880ac2ca96393d49
Autor:
G. A. Burnasheva, R. P. Myasnikov, O. V. Kulikova, M. M. Kudryavtseva, E. A. Mershina, O. M. Drapkina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 12 (2023)
Hypertrophic cardiomyopathy (HCM) at the cellular level is characterized by hypertrophy, cardiomyocyte disorganization and myocardial fibrosis areas. The leading death cause in HCM remains sudden cardiac death (SCD). Despite the existing risk scores
Externí odkaz:
https://doaj.org/article/b35a02bc6fba465f9fbc6224cca9874e
Autor:
R. P. Myasnikov, N. N. Kuzina, D. A. Nefedova, A. V. Kiseleva, O. V. Kulikova, A. N. Meshkov, M. M. Kudryavtseva, E. A. Mershina, M. g. Divashuk, E. V. Ryzhkova, M. S. Kharlap, O. M. Drapkina
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 11 (2023)
Inherited cardiomyopathies (CMP) are a group of heterogeneous diseases characterized by myocardial disorders that is not caused by coronary artery disease, hypertension, valvular and congenital defects. With the development of imaging methods and mol
Externí odkaz:
https://doaj.org/article/edf30b19433b45eba60ff5615a6f1553
Autor:
E. K. Yaralieva, I. A. Skripnikova, R. P. Myasnikov, O. V. Kulikova, V. E. Novikov, M. A. Myagkova, V. A. Vygodin, O. M. Drapkina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 8 (2023)
Aim. To evaluate bone mineral density (BMD) and parameters of bone metabolism in men with heart failure (HF) of various origins.Material and methods. The study included 100 men aged 20-70 years. The main group consisted of 60 men with HF, while the c
Externí odkaz:
https://doaj.org/article/bb9823dc19eb496e8521c92097e40787
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 7S (2023)
Diastolic myocardial dysfunction is the most important pathogenetic factor in heart failure and makes a significant contribution to hemodynamic disorders, which leads to a significant deterioration in the quality of life and prognosis of patients. Th
Externí odkaz:
https://doaj.org/article/27ef9063e04a41ec97fd7fdcc76efdeb